Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension - A pilot study

Proteomics - Clinical Applications

Volumn 3, Issue 12, 2009, Pages 1430-1439

  Rodríguez, Carlos E ^a   Arranz, José A ^a   Colomé, Nuria ^a   Bech Serra, Joan J ^a   Canals, Francesc ^a   Del Toro, Mireia ^a   Riudor, Encarnació ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Glycine encephalopathy; Idiopathic pulmonary hypertension; Methionine sulfoxidation; Nonketotic hyperglycinemia; Protein carbonylation

Indexed keywords

CYSTATIN C; MALONALDEHYDE; VITAMIN D BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; HYPERGLYCINEMIA; INFANT; LEUKOENCEPHALOPATHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN PROCESSING; PROTEOMICS; PULMONARY HYPERTENSION; SULFOXIDATION;

EID: 77951040822     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200800251     Document Type: Article

References (26)

1. Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D. The Metabolic and Molecular Bases of Inherited Disease, Vol 2, 8th ed., McGraw-Hill, New York 2001, pp. 2065-2078.
2. Applegarth, D. A., Toone, J. R., Glycine encephalopathy (nonketotic hyperglycinaemia): review and update J. Inherit. Metab. Dis. 2004, 27, 417-422.
3. Loscalzo, J., Genetic clues to the cause of primary pulmonary hypertension. N. Engl. J. Med. 2001, 345, 367-371.
4. Cataltepe, S., van Marter, L. J., Kozakewich, H., Wessel, D. L. et al. Pulmonary hypertension associated with nonketotic hyperglycinaemia. J. Inher. Metab. Dis. 2000, 23, 137-144.
5. Riudor, E., Urgellés, M., Colomer, L. et al., Familial pulmonary hypertension with nonketotic hyperglycinemia. 30th SSIEM Conference Leuven. 1992, A38.
6. Del Toro, M., Arranz, J. A., Macaya, A., Riudor, E. et al., Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertension. Ann. Neurol. 2006, 60, 148-152.
7. Finehout, E. J., Franck, Z., Lee, K. H., Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease. Dis. Markers 2005, 21, 93-101.
8. Davidsson, P., Sjogren, M., Andreasen, N., Lindbjer, M. et al., Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res. Mol. Brain Res. 2002, 109, 128-133.
9. Puchades, M., Hansson, S. F., Nilsson, C. L., Andreasen, N. et al., Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res. Mol. Brain Res. 2003, 118, 140-146.
10. Davidsson, P., Westman-Brinkmalm, A., Nilsson, C. L., Lindbjer, M. et al. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport 2002, 13, 611-615.
11. Piubelli, C., Fiorini, M., Zanusso, G., Milli, A. et al., Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping. Proteomics 2006, 6, S256-S261.
12. Raganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V. et al., Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005, 95, 1461-1471.
13. Vanderver, A., Schiffmann, R., Timmons, M., Kellersberger, K. A. et al., Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. Clin. Chem. 2005, 51, 2031-2042.
14. Riudor, E., Arranz, J. A., del Toro, M. et al. A new presentation of nonketotic hyperglycinaemia with primary pulmonary hypertension and branched chain acylglycines with fatal outcome in three families. J. Inherit. Metab. Dis. 2001, 24, Suppl 1, 35.
15. Canals, F., Colomé, N., Ferrer, C., Plaza-Calonge, Mdel C., Rodríguez-Manzaneque, J. C., Identification of substrates of the extracellular protease ADAMTS1 by DIGE proteomic analysis. Proteomics 2006, 6, S28-S35.
16. Hu, Y., Malone, J. P., Fagan, A. M., Townsend, R. R., Holtzman, D. M., Comparative proteomic analysis of intraand interindividual variation in human cerebrospinal fluid. Mol. Cell Proteom. 2005, 4, 2000-2009.
17. Reiber, H., Peter, J. B., Cerebrospinal fluid analysis: diseaserelated data patterns and evaluation programs. J. Neurol. Sci. 2001, 184, 101-122.
18. Reiber, H., Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 2001, 310, 173-186.
19. Brechlin, P., Jahn, O., Steinacker, P., Cepek, L. et al., Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D-DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease. Proteomics 2008, 8, 4357-4366.
20. Choi, J., Malakowsky, C. A., Talent, J. M., Conrad, C. C., Gracy, R. W., Identification of oxidized plasma proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun. 2002, 293, 1566-1570.
21. Choi, J., Forster, M. J., McDonald, S. R., Weintraub, S. T. et al., Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. Free Radic. Biol. Med. 2004, 36, 1155-1162.
22. Korolainen, M. A., Nyman, T. A., Nyyssönen, P., Hartikainen, E. S., Pirttila., T., Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin. Chem. 2007, 53, 657-665.
23. Carrette, O., Burkhard, P. R., Hughes, S., Hochstrasser, D. F., Sanchez, J. C., Truncated cystatin C in cerebrospinal fluid: Technical artefact or biological process? Proteomics 2005, 5, 3060-3065.
24. Nyström, T., Role of oxidative carbonylation in protein quality control and senescence. EMBO J. 2005, 24, 1311-1317.
25. Lingling, L., Marcocci, L., Ming, C. W., Park, A. -M., Suzuki, Y. J. Serotonin-mediated protein carbonylation in the right heart. Free Radic. Biol. Med. 2008, 45, 847-854.
26. Van der Knaap, M. S., Pronk, J. C., Scheper, G. C., Vanishing white matter disease. Lancet Neurol. 2006, 5, 413-423.